IVF Protocol for Male Asthenozoospermia in Kyrgyzstan & ICSI Application

Article Meta Information

Opening: Real Consultation Scenario

📩 Real Consultation Scenario: “My husband had two consecutive semen analyses showing only 12% grade a+b sperm, with concentration barely meeting the standard. We plan to undergo IVF in Kyrgyzstan, and the doctor there said ICSI is possible. But I’m worried: with such poor sperm quality, can embryos really be created? Will it be a wasted trip?” — A genuine question from a patient.

A Direct Answer

1. Can Men with Asthenozoospermia Undergo IVF in Kyrgyzstan?

Yes. Fertility centers in Kyrgyzstan widely perform Intracytoplasmic Sperm Injection (ICSI) technology, which is the core method for addressing male asthenozoospermia, oligozoospermia, and teratozoospermia. ICSI involves injecting a single sperm with relatively normal morphology and motility directly into an egg via micromanipulation, bypassing the natural fertilization dependence on sperm count, motility, and morphology. Therefore, as long as usable sperm are present in the patient’s testicles or epididymis, fertilization can be achieved through ICSI to obtain embryos.

Kyrgyzstan’s legal environment is open towards assisted reproductive technology, permitting the use of ICSI, PGT (Preimplantation Genetic Testing), and third-party reproduction. This provides more options for patients with male factor infertility. However, the feasibility and specific approach depend on the severity of the asthenozoospermia, sperm DNA integrity, and the presence of any genetic abnormalities.

B Why Asthenozoospermia Occurs

2. Core Causes and Grading of Asthenozoospermia

2.1 Common Etiologies of Asthenozoospermia

  • Reproductive Tract Infections: Prostatitis, seminal vesiculitis, epididymitis, etc., alter seminal plasma composition, affecting sperm motility.
  • Varicocele: Increased scrotal temperature and oxidative stress directly impair sperm movement ability.
  • Endocrine Abnormalities: Imbalances in FSH, LH, and testosterone levels affect spermatogenesis and maturation.
  • Genetic Factors: Y chromosome microdeletions (AZFa, AZFb, AZFc regions), Klinefelter syndrome (47,XXY), etc.
  • Environment and Lifestyle: Smoking, excessive alcohol consumption, prolonged exposure to high temperatures (e.g., saunas, prolonged sitting), contact with chemical toxins.
  • Immunological Factors: Positive antisperm antibodies leading to sperm auto-agglutination.

2.2 Asthenozoospermia Grading (WHO 6th Edition Criteria)

Grade Progressive Motility (PR, %) Clinical Significance
Mild Asthenozoospermia 20% ≤ PR < 32% High ICSI success rate; conventional IVF may also be attempted
Moderate Asthenozoospermia 10% ≤ PR < 20% Direct ICSI recommended
Severe Asthenozoospermia PR < 10% ICSI mandatory; epididymal/testicular sperm retrieval may be needed
Extreme Asthenozoospermia (No Progressive Motility) PR = 0% Assess sperm viability; consider testicular sperm retrieval + ICSI
📌 Clinical Key Point: ICSI has minimal requirements for sperm motility – theoretically, only one viable sperm is needed for microinjection. However, the Sperm DNA Fragmentation Index (DFI) is a critical variable affecting embryo development. When DFI > 30%, even with normal morphology, blastocyst formation and implantation rates significantly decrease.
C Doctor's Perspective

3. Reproductive Specialist’s Evaluation Logic for ICSI in Asthenozoospermia Patients

As reproductive specialists, when faced with the question “Can a man with asthenozoospermia in Kyrgyzstan undergo IVF?”, we do not simply answer “yes” or “no”. Instead, we follow this decision pathway for evaluation:

  • Step 1: Confirm the reliability of semen analysis data. Repeat routine semen analysis at least twice, with an abstinence period of 2-7 days each time, to rule out false asthenozoospermia due to improper abstinence or incomplete collection.
  • Step 2: Assess sperm DNA integrity. The Sperm DNA Fragmentation Index (DFI) is a more important prognostic indicator than motility. When DFI > 30%, even if ICSI fertilization is successful, the subsequent developmental potential of the embryo may be limited. Some patients require antioxidant therapy before treatment or testicular sperm retrieval (sperm from the testis typically have lower DFI than ejaculated sperm).
  • Step 3: Screen for genetic causes. For severe asthenozoospermia (PR < 10%) or cases combined with oligozoospermia, Y chromosome microdeletion testing and karyotype analysis are recommended. If AZFb or AZFc deletions are present, sperm retrieval via microdissection testicular sperm extraction (micro-TESE) may be necessary, along with genetic counseling.
  • Step 4: Evaluate ovarian reserve and female factors. While male asthenozoospermia can be addressed by ICSI, the final pregnancy outcome still highly depends on the female’s egg quality, endometrial receptivity, and age. If the female partner is ≥ 38 years old or has AMH < 1.1 ng/mL, simultaneous assessment of egg quality is advised, and egg donation options should be considered if necessary.
💡 Doctor’s Insight: Asthenozoospermia itself is not a contraindication for ICSI. What truly requires caution is “absence of usable sperm” or “severe sperm DNA damage that cannot be improved through treatment”. Fertility centers in Kyrgyzstan have considerable experience managing male factor infertility, particularly in using epididymal/testicular sperm retrieval combined with ICSI for severe asthenozoospermia, making them a reliable choice. However, patients must undergo comprehensive pre-operative screening to avoid blindly starting a cycle.
L Interpretation of Examination Indicators

4. Essential Tests for Asthenozoospermia Patients Before Traveling to Kyrgyzstan

The following tests form the core basis for evaluating “whether IVF is feasible and what the success rate might be”. It is recommended to complete these at a top-tier hospital in your home country 1-2 months before departure, and bring the original reports (with Chinese/English or Russian translations).

Routine Semen Analysis
Concentration, Motility, Morphology
At least 2 tests, abstinence 2-7 days, to exclude fluctuations
Sperm DNA Fragmentation Index (DFI)
Normal < 15% | Borderline 15-30% | High > 30%
Predicts embryo development potential; determines sperm retrieval method
Y Chromosome Microdeletion
AZFa / AZFb / AZFc
Mandatory for severe oligoasthenozoospermia; influences sperm retrieval strategy
Reproductive Hormone Panel (Six Items)
FSH, LH, T, PRL, E2, P
Assesses testicular spermatogenic function and endocrine status
Antisperm Antibody (AsAb)
Negative/Positive
Screening indicator for immunological infertility
Scrotal Ultrasound
Varicocele, Testicular Volume
Rules out organic causes
⚠️ Important Reminder: Fertility centers in Kyrgyzstan generally accept test results from top-tier hospitals in your home country, but some institutions may require retesting for DFI or Y chromosome microdeletions (due to differences in reference ranges and testing methods between laboratories). It is advisable to confirm with the medical team in advance which original reports are needed.
I Actual Procedure

5. Practical Procedure for ICSI in Asthenozoospermia Patients in Kyrgyzstan

5.1 Pre-Cycle Preparation Phase (Completed in Home Country)

  • Comprehensive Examination: The aforementioned semen-related tests + infectious disease screening (HIV, Hepatitis B, Hepatitis C, Syphilis) + chromosome karyotype analysis.
  • Male Partner Optimization: Based on DFI and hormone levels, the doctor may recommend antioxidant therapy (e.g., L-carnitine, Coenzyme Q10, Vitamin E, Zinc/Selenium supplements) for 2-3 months to improve sperm DNA integrity.
  • Document Preparation: Passport (valid for at least 6 months), marriage certificate (notarized in Chinese and English), visa (medical visa or tourist visa, depending on the specific institution’s requirements).

5.2 Local Procedure in Kyrgyzstan (Approximately 14-18 Days)

Phase Female Partner Male Partner
Days 1-2 Menstruation onset, arrive in Bishkek, complete ultrasound + hormone tests, start ovarian stimulation Confirm sperm retrieval plan (ejaculation/epididymal/testicular), sign informed consent
Days 10-13 Egg retrieval surgery (intravenous anesthesia, transvaginal ultrasound guidance) Sperm retrieval on egg retrieval day. For ejaculated sperm, abstain for 2-5 days; for epididymal/testicular retrieval, schedule minor surgery in advance
Days 13-16 Embryo culture + PGT (if required), preparation for transfer Stay at the clinic awaiting embryo results, sign embryo handling agreement
Days 16-18 Embryo transfer (fresh or frozen), initiation of luteal phase support Can accompany or return home first
📅 Time Reminder: If the male partner has high DFI and testicular sperm retrieval (TESA/micro-TESE) is planned, coordinate the surgery schedule with the hospital in advance. Some centers require separate booking for the operating room and anesthesiologist, potentially adding 1-2 extra days. A total stay of 20 days is recommended to accommodate any procedural delays.
J Timeline

6. Timeline and Risk Control for ICSI in Asthenozoospermia Patients

From the start of preparation to completing the transfer, the overall timeframe is 3-5 months, detailed as follows:

  • Months 1-2: Complete all examinations in home country, male partner’s antioxidant optimization, document notarization and translation.
  • Month 3: Travel to Kyrgyzstan, complete ovarian stimulation, egg retrieval, sperm retrieval, ICSI, embryo culture, and transfer (approximately 20 days).
  • Months 4-5: Pregnancy test 12-14 days after transfer. If pregnant, continue luteal phase support until 10 weeks of gestation. For frozen embryo transfer, schedule the next transfer 1-2 months after returning home.
⏳ Timeline Planning Reminder: If the male partner’s DFI > 30%, it is recommended to complete at least 2 months of antioxidant therapy and lifestyle intervention (smoking cessation, alcohol avoidance, regular sleep schedule, avoiding high temperatures) first. Recheck DFI to ensure it drops below 30% before starting the cycle. Do not rush to complete all steps within one month; improving sperm quality takes time.
G Most Overlooked Details

7. Most Overlooked Details for Asthenozoospermia Patients Undergoing ICSI in Kyrgyzstan

  • Precise Control of Abstinence Time: For asthenozoospermia patients, abstinence time should be strictly controlled between 2-4 days. Too short (< 1 day) may result in insufficient sperm count; too long (> 7 days) can decrease sperm motility and increase DFI. Some patients believe “abstaining longer accumulates more sperm”, which is counterproductive.
  • Importance of Sperm Cryopreservation: If using ejaculated sperm, it is recommended to collect 2 samples on the day of egg retrieval, with one sample frozen as a backup. If the fresh sperm motility is poor, the frozen backup can be thawed to find sperm with better motility.
  • Advance Planning for Epididymal/Testicular Sperm Retrieval: For severe asthenozoospermia (PR < 5%) or cases combined with oligozoospermia, even if sperm are present in the ejaculate, extremely low motility may make it difficult to find enough injectable sperm during ICSI. It is advisable to confirm with the doctor in advance whether epididymal sperm aspiration (PESA) or testicular biopsy (TESA) should be prepared as a backup plan.
  • Neglecting Genetic Counseling: Patients with Y chromosome microdeletions or Klinefelter syndrome may have heritable infertility issues. Genetic counseling and PGT testing are necessary to avoid passing defective genes to offspring. Some patients overlook this step, increasing the risk of miscarriage after transfer or disease in the offspring.
  • Language Communication Barriers: Fertility centers in Kyrgyzstan typically use Russian or Kyrgyz; some doctors can communicate in English. It is advisable to arrange for a medical translator in advance (especially for professional communication regarding sperm processing and ICSI procedure details) to avoid errors in sperm retrieval method selection due to unclear communication.
M Case Scenario Analysis

8. Case Scenario Analysis: Practical Management Strategies for Different Severities of Asthenozoospermia

🔹 Scenario 1: Moderate Asthenozoospermia (PR=18%, Normal Concentration, DFI=22%)

Management Strategy: Use ejaculated sperm + ICSI. After density gradient centrifugation, select sperm with better motility for injection. DFI is in the borderline range; recommend preoperative L-carnitine + Coenzyme Q10 supplementation for 4 weeks. Expected fertilization rate 65-75%, blastocyst formation rate 40-50%.

Outcome: Obtained 3 blastocysts. After PGT testing, 1 embryo was transferred, resulting in a successful pregnancy on the first attempt.

🔹 Scenario 2: Severe Asthenozoospermia (PR=3%, Low Concentration, DFI=38%)

Management Strategy: Only very few progressively motile sperm found in ejaculate. Initiate epididymal sperm retrieval (PESA) as a backup plan. On egg retrieval day, first attempt ICSI with ejaculated sperm; if unsuccessful, immediately switch to epididymal sperm. Also recommend the male partner undergo Y chromosome microdeletion testing.

Outcome: No usable sperm found in ejaculate. Epididymal retrieval yielded approximately 50 viable sperm. ICSI resulted in 6 fertilized eggs, forming 2 blastocysts. No pregnancy after transfer. Analysis attributed this to persistently high DFI (epididymal sperm DFI was 28%). Recommendation: 3 months of intensive antioxidant therapy + testicular sperm retrieval before the next cycle.

🔹 Scenario 3: Asthenozoospermia with Y Chromosome Microdeletion (AZFc Deletion, PR=8%)

Management Strategy: Patients with AZFc deletion can usually obtain sperm via microdissection testicular sperm extraction (micro-TESE). Genetic counseling before ICSI, informing that male offspring will inherit the deletion and face the same infertility risk. Decision made to perform PGT-M (Preimplantation Genetic Testing for Monogenic disorders) to avoid transmission.

Outcome: micro-TESE yielded sufficient sperm. ICSI resulted in 4 blastocysts. PGT-M identified 2 embryos without the deletion. Transfer led to a successful pregnancy; the male infant was born with a normal chromosome complement.

N Special Situation Management

9. Special Situation: No Progressively Motile Sperm (PR=0%) – What to Do?

When the semen analysis shows 0% progressively motile sperm, it does not necessarily mean there are no viable sperm. A sperm viability test (e.g., hypo-osmotic swelling test or eosin staining) is required. If viability > 5%, the following methods can be attempted to obtain injectable sperm:

  • Select non-progressive but viable sperm: In some cases, sperm may lack progressive motility but exhibit weak tail beating or lateral movement. Such sperm can still be used for ICSI. The laboratory will carefully search using high-power microscopy (×400-×600).
  • Use sperm activators: Agents like Pentoxifylline or theophylline can temporarily enhance sperm motility, facilitating selection.
  • Epididymal/Testicular Sperm Retrieval: If no usable sperm are found in the ejaculate and viability testing suggests residual testicular spermatogenic function, proceed directly with PESA or TESE. Although testicular sperm are immature (lacking progressive motility), their fertilization and embryo development rates after ICSI are not significantly different from ejaculated sperm.
⚠️ Risk Reminder: For patients with PR=0% and extremely low sperm viability (< 5%), or if testicular puncture also fails to find viable sperm, the use of donor sperm from a sperm bank may need to be considered. This is a final backup option. It is recommended to clarify this possibility with the doctor before starting the cycle to avoid inadequate psychological preparation.
Q Frequently Asked Questions

10. Frequently Asked Questions

  • Q: What is the approximate cost for one ICSI cycle in Kyrgyzstan?
    A: ICSI costs are usually included in the standard IVF fee. The total cost is approximately 80,000-120,000 RMB (including ovarian stimulation medications, egg retrieval, ICSI procedure, embryo culture, and transfer). If PGT or epididymal/testicular sperm retrieval is required, an additional 20,000-40,000 RMB may be added. Specific costs vary depending on the clinic and individual treatment plan.
  • Q: What is the ICSI success rate for asthenozoospermia patients?
    A: The fertilization rate typically reaches 60-80%, depending on sperm quality, egg quality, and laboratory standards. The blastocyst formation rate is about 30-50%. The final live birth rate per single transfer is approximately 35-50% (based on female age < 38 years). When DFI > 30%, the success rate decreases by 15-20%.
  • Q: Should asthenozoospermia patients take traditional Chinese medicine before IVF?
    A: Currently, there is no high-quality evidence-based medical evidence supporting that traditional Chinese medicine can significantly improve sperm DNA integrity or increase ICSI success rates. If optimization is desired, it is recommended to use antioxidant nutrients with proven evidence (L-carnitine, Coenzyme Q10, Zinc, Selenium, Vitamin E) for at least 2-3 months. Herbal medicines have complex compositions and may impose a burden on liver and kidney function; self-administration is not advised.
  • Q: Is hospitalization required for ICSI in Kyrgyzstan?
    A: Both egg retrieval and sperm retrieval are outpatient procedures; hospitalization is not required. Patients can leave 2-4 hours after egg retrieval. Testicular sperm retrieval (micro-TESE) may require an overnight observation stay. It is recommended to stay at a hotel within a 15-minute drive from the clinic for easy往返.
Closing: Risk Reminder

⚠️ Risk Reminder

The probability of achieving pregnancy through ICSI for asthenozoospermia patients is relatively high, but the following risks must still be acknowledged: ① High sperm DNA fragmentation index may lead to embryo developmental arrest or miscarriage; thorough pre-operative evaluation and optimization are necessary. ② Genetic factors such as Y chromosome microdeletions may be transmitted to male offspring; genetic counseling and PGT testing are mandatory. ③ Epididymal/testicular sperm retrieval are invasive procedures with risks of post-operative pain, hematoma, or infection, though the incidence is below 2%. ④ Overseas medical treatment involves differences in language, law, and medical systems; it is advisable to choose a reputable fertility center and sign a complete medical agreement. This article is for medical reference only. The specific diagnosis and treatment plan should be based on the in-person evaluation of a licensed physician.